{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:20:55Z","timestamp":1761895255080},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.amjopharm.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,4,2]],"date-time":"2011-04-02T00:07:14Z","timestamp":1301702834000},"page":"37-48","source":"Crossref","is-referenced-by-count":11,"title":["Identification, Pharmacologic Considerations, and Management of Prostatitis"],"prefix":"10.1016","volume":"9","author":[{"given":"Daryl S.","family":"Schiller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2011.02.005_bib1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.urology.2005.05.034","article-title":"Correlates and prevalence of prostatitis in a large community-based cohort of older men","volume":"66","author":"Daniels","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib2","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.juro.2007.01.128","article-title":"Prostatitis","volume":"177","author":"Pontari","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib3","series-title":"Atlas of Human Anatomy","author":"Netter","year":"2010"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib4","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1086\/652861","article-title":"Treatment of bacterial prostatitis","volume":"50","author":"Lipsky","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2011.02.005_bib5","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.3949\/ccjm.74.Suppl_3.S63","article-title":"Prostatitis: Infection, neuromuscular disorder, or pain syndrome?","volume":"74","author":"Potts","year":"2007","journal-title":"Cleve Clin Med J"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2008.12.067","article-title":"Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy","volume":"74","author":"Ozden","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib7","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1517\/14656566.8.11.1667","article-title":"Therapy for prostatitis, with emphasis on bacterial prostatitis","volume":"8","author":"Wagenlehner","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib8","first-page":"370","article-title":"Prostatitis after urethritis in Singapore","volume":"50","author":"Thin","year":"1974","journal-title":"Brit J Vener Dis"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/pros.20916","article-title":"IL-1 beta-induced post-transition effect of NK-KappaB provides time-dependent wave of signals for initial phase of intraprostatic inflammation","volume":"69","author":"Vykhovanets","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"281","author":"Kreiger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007435-198404000-00011","article-title":"Prostatitis sydromes: pathophysiology, differential diagnosis, and treatment","volume":"11","author":"Kreiger","year":"1984","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-5347(05)68562-X","article-title":"The National Institute of Health chronic prostatitis symptom index:development and validation of a new outcome measure","volume":"162","author":"Litwin","year":"1999","journal-title":"J Urol"},{"issue":"Suppl 6","key":"10.1016\/j.amjopharm.2011.02.005_bib13","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0090-4295(02)02296-3","article-title":"A review of the development and validation of the National Institute of Health Chronic Prostatitis Symptom Index","volume":"60","author":"Litwin","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11136-005-1317-1","article-title":"Responsiveness of the National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI)","volume":"15","author":"Propert","year":"2006","journal-title":"Qual Life Res"},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2011.02.005_bib15","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.ijantimicag.2007.08.028","article-title":"Epidemiology of prostatitis","volume":"31","author":"Kreiger","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib16","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0022-5347(01)63564-X","article-title":"How common is prostatitis?","volume":"159","author":"Collins","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(02)02081-2","article-title":"Chronic prostatitis: symptom survey with follow-up clinical evaluation","volume":"61","author":"Cheah","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib18","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.juro.2007.05.140","article-title":"Prevalence of and risk factors for prostatitis: Population based assessment using physician assigned diagnoses","volume":"178","author":"Clemens","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.juro.2006.03.089","article-title":"Prevalence of prostatitis-like symptoms in a managed care population","volume":"176","author":"Clemens","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1464-410X.2000.00836.x","article-title":"Epidemiology of prostatitis in Finnish men: A population-based cross-sectional study","volume":"86","author":"Mehik","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib21","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/S0022-5347(05)64170-5","article-title":"Prevalence of prostatitis-like symptoms in a community based cohort of older men","volume":"168","author":"Roberts","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib22","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.ju.0000132797.63480.44","article-title":"Prognosis of patients with new prostatitis\/pelvic pain syndrome episodes","volume":"1752;","author":"Turner","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2334-8-12","article-title":"Acute bacterial prostatitis: Heterogeneity in diagnostic criteria and management","volume":"8","author":"Etienne","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.pcan.4500604","article-title":"Management of prostatitis","volume":"5","author":"Gurunadha","year":"2002","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib25","first-page":"38","article-title":"The pre and post massage test (PPMT): A simple screen for prostatitis","volume":"3;","author":"Nickel","year":"1997","journal-title":"Tech Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000074526","article-title":"Penetration of antimicrobial agents into the prostate","volume":"49","author":"Charalabopoulos","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1179\/joc.2008.20.2.213","article-title":"Determination of the concentration of ciprofloxacin in prostate tissue following administrtaion of a single, 1000 mg, extended-release dose","volume":"20","author":"Lugg","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1179\/joc.2006.18.5.485","article-title":"Serum and prostatic tissue concentrations of moxifloxacin in patients undergonig transurethral resection of the prostate","volume":"18","author":"Wagenlehner","year":"2006","journal-title":"J Chemothe.r"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02013607","article-title":"The penetration of antibiotics into the prostate in chronic bacterial prostatitis","volume":"3","author":"Barza","year":"1984","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib30","first-page":"443","article-title":"Antibiotic tissue penetration","volume":"59","author":"Cunha","year":"1983","journal-title":"Bull N Y Acad Med"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0378-5173(90)90130-V","article-title":"Aqueous solubilities of some variously substituted quinolone antimicrobials","volume":"63","author":"Ross","year":"1990","journal-title":"Internat J Pharmaceutics"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib32","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/AAC.44.8.2046-2051.2000","article-title":"A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin","volume":"44","author":"Drusano","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cger.2009.04.004","article-title":"Drug dosing in the elderly patients with chronic kidney disease","volume":"25;","author":"Olyaei","year":"2009","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2214\/ajr.155.3.2117353","article-title":"The thickness of the renal parenchyma decreases with age: A CT study of 360 patients","volume":"155","author":"Gourtsoyiannis","year":"1990","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00002512-199404020-00007","article-title":"Ciprofloxacin","volume":"4","author":"Wiseman","year":"1994","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/11531490-000000000-00000","article-title":"Safety considerations of fluoroquinolones in the elderly: An update","volume":"27","author":"Stahlmann","year":"2010","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib37","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0022-5347(01)66357-2","article-title":"Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretions","volume":"155","author":"Persson","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1464-410X.1982.tb13635.x","article-title":"Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis","volume":"54","author":"Kirby","year":"1982","journal-title":"Br J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0924-8579(02)00115-2","article-title":"Antibacterial effect of intraprostatic zinc injection in a rat model of chronic bacterial prostatitis","volume":"19","author":"Yong-Hyun","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijantimicag.2008.03.014","article-title":"Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis","volume":"32","author":"Naber","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0090-4295(03)00565-X","article-title":"Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prosatitis: A randomized double-blind multicenter study","volume":"62","author":"Bundrick","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ucl.2009.08.005","article-title":"Genitourinary pain syndromes, prostatitis, and lower urinary tract symptoms","volume":"36","author":"Le","year":"2009","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib43","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0924-8579(03)00056-6","article-title":"Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis","volume":"21","author":"Skerk","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1","key":"10.1016\/j.amjopharm.2011.02.005_bib44","first-page":"24","article-title":"Use of antibiotics in chronic prostatitis syndromes","volume":"8","author":"Shoskes","year":"2001","journal-title":"Can J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.amjmed.2008.01.043","article-title":"Excessive antibiotic use in men with prostatitis","volume":"121","author":"Taylor","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib46","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/01.ju.0000055549.95490.3c","article-title":"Long-term results of multimodal therapy for chronic prostatitis\/chronic pelvic pain syndrome","volume":"169","author":"Shoskes","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.eururo.2006.09.036","article-title":"A placebo-controlled comparison of the efficacy of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS)","volume":"51","author":"Tu\u011fcu","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib48","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1097\/01.ju.0000158445.68149.38","article-title":"A prospective, randomized, placebo controlled, double-blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 Year of followup","volume":"173","author":"Rowe","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib49","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.urology.2008.10.047","article-title":"Electroacupunture relieves pain in men with chronic prostatitis\/chronic pelvic pain syndrome: Three-arm randomized trial","volume":"73","author":"Lee","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib50","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.juro.2009.04.022","article-title":"Randomized multicenter feasibility frial of myofascial physical therapy for treatment of urologic chronic pelvic pain syndromes","volume":"182","author":"Fitzgerald","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib51","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1464-410X.2003.04766.x","article-title":"A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)","volume":"93","author":"Nickel","year":"2004","journal-title":"BJU Internat"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib52","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.ju.0000054983.45096.16","article-title":"A Randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis","volume":"169","author":"Nickel","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib53","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1590\/S0100-879X2009005000021","article-title":"Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (category IIIA)","volume":"42","author":"Zhao","year":"2009","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib54","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0090-4295(99)00358-1","article-title":"Quercetin in men with category III chronic prostatitis: A preliminary prospective, double-blind, placebo-controlled trial","volume":"54","author":"Shoskes","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib55","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1056\/NEJMoa0803240","article-title":"Alfuzosin and symptoms of chronic prostatitis\u2013Chronic pelvic pain syndrome","volume":"359","author":"Nickel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0090-4295(03)00466-7","article-title":"Alfuzosin treatment for chronic prostatitis\/chronic pelvic pain syndrome: A prospective, randomized, double-blind, placebo-controlled, pilot study","volume":"62","author":"Mehik","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib57","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0022-5347(05)63960-2","article-title":"Terazosin therapy for chronic prostatitis\/chronic pelvic pain syndrome: A randomized, placebo controlled trial","volume":"169","author":"Cheah","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib58","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/01.ju.0000117811.40279.19","article-title":"Treatment of chronic prostatitis\/chronic pelvic pain syndrome with tamsulosin: A randomized double blind trial","volume":"171","author":"Nickel","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-141-8-200410190-00005","article-title":"Ciprofloxacin or tamsulosin in men with chronic prostatitis\/chronic pelvic pain syndrome: A randomized double-blind trial","volume":"141","author":"Alexander","year":"2004","journal-title":"Ann Inten Med"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib60","first-page":"65","article-title":"Antibiotics and alpha-blockers for chronic prostatitis: Evidence from recent randomized placebo-controlled studies","volume":"7","author":"Nickel","year":"2005","journal-title":"Rev Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1442-2042.1999.06338.x","article-title":"Role of ejaculation in the treatment of chronic non-bacterial prostatitis","volume":"6","author":"Yava\u015f\u00e7ao\u011flu","year":"1999","journal-title":"Int J Urol"},{"issue":"Suppl 6","key":"10.1016\/j.amjopharm.2011.02.005_bib62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0090-4295(02)02390-7","article-title":"Bladder training biofeedback and pelvic floor myalgia","volume":"60","author":"Nadler","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib63","first-page":"155","article-title":"Biofeedback therapy for chronic pelvic pain syndrome","volume":"5","author":"Ye","year":"2003","journal-title":"Asian J Androl"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib64","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0090-4295(03)00141-9","article-title":"Acupuncture ameliorates symptoms in men with chronic prostatitis\/chronic pelvic pain syndrome (CP\/CPPS)","volume":"61","author":"Chen","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1442-2042.1998.tb00267.x","article-title":"Transrectal microwave hyperthermia for patients with benign prostatic hyperplasia","volume":"5","author":"Barbalias","year":"1998","journal-title":"Int J Urol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib66","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/end.1995.9.333","article-title":"Is there a role for transrectal microwave hyperthermia in the treatment of benign prostatic hyperplasia?","volume":"9","author":"Montorsi","year":"1995","journal-title":"J Endourol"},{"key":"10.1016\/j.amjopharm.2011.02.005_bib67","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0022-5347(01)66056-7","article-title":"Transurethral microwave thermotherapy for nonbacterial prostatitis: A randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires","volume":"155","author":"Nickel","year":"1996","journal-title":"J Urol"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T20:51:11Z","timestamp":1543870271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594611000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1543594611000092"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2011.02.005","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}